Small molecule drugs, widely developed by researchers worldwide, are recognized to have a significant impact on the treatment of cancer. However, meeting the high regulatory criteria set by the FDA and other regulatory authorities has become a challenging issue for medication registrations and approvals. Therefore, we put a lot of effort into it and endeavored to create a set of IND regulatory services to aid researchers during the lifecycle management of your products to comply with the pharmaceutical registrations and approvals. This review aims to outline the advantages of our services and introduce the types of assistance Creative Biolabs will provide with IND regulatory services.

Here is a preview of the list:

1. Regulatory Medical Writing and Translation
2. IND publication and submission
3. Post-IND maintenance